B3GNT3
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3
Also known as: B3GN-T3, B3GN3_HUMAN, B3GNT-3, beta3Gn-T3, HP10328, TMEM3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y2A9
- Gene
- B3GNT3
- Ensembl
- ENSG00000179913
- Chromosome
- 19
- Canonical length
- 372 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a member of the beta-1,3-N-acetylglucosaminyltransferase family. This enzyme is a type II transmembrane protein and contains a signal anchor that is not cleaved. It prefers the substrates of lacto-N-tetraose and lacto-N-neotetraose, and is involved in the biosynthesis of poly-N-acetyllactosamine chains and the biosynthesis of the backbone structure of dimeric sialyl Lewis a. It plays dominant roles in L-selectin ligand biosynthesis, lymphocyte homing and lymphocyte trafficking. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
372 residues, UniProt reviewed canonical sequence.
>Q9Y2A9|B3GNT3
1 MKYLRHRRPN ATLILAIGAF TLLLFSLLVS PPTCKVQEQP PAIPEALAWP TPPTRPAPAP
61 CHANTSMVTH PDFATQPQHV QNFLLYRHCR HFPLLQDVPP SKCAQPVFLL LVIKSSPSNY
121 VRRELLRRTW GRERKVRGLQ LRLLFLVGTA SNPHEARKVN RLLELEAQTH GDILQWDFHD
181 SFFNLTLKQV LFLQWQETRC ANASFVLNGD DDVFAHTDNM VFYLQDHDPG RHLFVGQLIQ
241 NVGPIRAFWS KYYVPEVVTQ NERYPPYCGG GGFLLSRFTA AALRRAAHVL DIFPIDDVFL
301 GMCLELEGLK PASHSGIRTS GVRAPSQRLS SFDPCFYRDL LLVHRFLPYE MLLMWDALNQ
361 PNLTCGNQTQ IYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against B3GNT3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 41 nTPM
Expression across tissuesHPA
Tissue
- colon: 41 nTPM
- stomach: 41 nTPM
- rectum: 38 nTPM
- duodenum: 31 nTPM
- small intestine: 28 nTPM
- salivary gland: 26 nTPM
Single-cell type
- esophageal apical cells: 217 nCPM
- colonocytes: 123 nCPM
- cytotrophoblasts: 115 nCPM
- foveolar cells: 110 nCPM
- enterocytes: 97 nCPM
- syncytiotrophoblasts: 89 nCPM
Immune cell
- memory CD4 T-cell: 0.7 nTPM
- naive CD4 T-cell: 0.7 nTPM
- memory CD8 T-cell: 0.2 nTPM
- total PBMC: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- cerebellum: 1.5 nTPM
- cerebral cortex: 1 nTPM
- hippocampal formation: 0.8 nTPM
- pons: 0.7 nTPM
- amygdala: 0.5 nTPM
- hypothalamus: 0.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.54
- gnomAD pLI
- 0.74
- gnomAD missense Z
- 1.52
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- keratan sulfate proteoglycan biosynthetic process
- poly-N-acetyllactosamine biosynthetic process
- protein O-linked glycosylation
- protein O-linked glycosylation via N-acetyl-galactosamine
Molecular functions
- beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity
- N-acetyl-beta-D-glucosaminide beta-(1,3)-galactosyltransferase activity
- N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads B3GNT3 as an antibody target. Whether an autoantibody or antibody against B3GNT3 could matter depends on whether native B3GNT3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
B3GNT3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label B3GNT3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...